NCT06086015View on ClinicalTrials.gov

Apply tACS to Alleviate Anxiety Symptoms

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Anxiety Disorders
Interventions
DEVICE

transcranial alternating current stimulation (tACS)

2mA tACS over right hemisphere, at positions F4, P4, T8 (10-10 convention)

Trial Locations (1)

07856

RECRUITING

NCI Clinical Research Foundation, Mount Arlington

All Listed Sponsors
lead

NeuroCognitive and Behavioral Institute Clinical Research Foundation

OTHER

NCT06086015 - Apply tACS to Alleviate Anxiety Symptoms | Biotech Hunter | Biotech Hunter